Individual non-covered health service: "Manager check" - blood count and immune parameters;IGeL kritisch betrachtet: "Manager check" - Teil 1: Blutbild und immunparameter

Zeitschrift fur Allgemeinmedizin

Volumn 85, Issue 4, 2009, Pages 165-170

  Strametz, Reinhard ^a   Erler, Antje ^a   Weberschock, Tobias ^a   Otterbach, Isabelle ^a   Beyer, Martin ^a  

^a GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

Author keywords

Blood count; Critical appraisal; Immunoglobulines; Lymphocyte subtyping; Medical services on individual demand (iGeL)

Indexed keywords

BLOOD CELL COUNT; EARLY DIAGNOSIS; FOLLOW UP; HEALTH SERVICE; HUMAN; IMMUNE FUNCTION TEST; IMMUNOGLOBULIN BLOOD LEVEL; LABORATORY TEST; LYMPHOCYTE TYPING; MORBIDITY; MORTALITY; REVIEW;

EID: 77249132574     PISSN: 09376801     EISSN: 14399229     Source Type: Journal    
DOI: 10.3238/zfa.2009.0165     Document Type: Review

References (25)

1. Baenkler H-W, Innere Medizin - Duale Reihe, Sonderauflage, Thieme, Stuttgart
2. Chacko KM, Feinberg LE. Laboratory Screening at Preventive Health Exams. J Prev Med. 2007;32:59-62
3. Witte DL, Angstadt DS, Schweitzer JK. Chemistry Profiles in "Wellness Programs": Test Selection and Participant Outcomes. Clin Chem. 1988;34:1447-50
4. Smetana GW, Macpherson DS. The case against routine preoperative laboratory testing. Med Clin N Am. 2003;87:7-40
5. Takemura Y. Ishida H, Inoue Y, Beck JR. Common Diagnostic Test Panel for Clinical Evaluation of New Primary Care Outpatients in Japan: A Cost-Effectiveness Evaluation. Clin Chem 1999;45:1752-61
6. Bhuripanyo K, Leowattana A, Ruangratanaampron O, Mahanonda N, Sriratanasathavorn C, Chotinaiwattarakul C. Are routine checkups necessary? The Shinawatra's Employee Study. J Med Assoc Thai. 2000;83, Suppl 2:163-71
7. Spivak JL, Barosi G, Tognoni G, Barbui T, Finazzi G, Marchioli R, Marchetti M. Chronic Myeloproliferative Disorders. Hematology Am Soc Hematol Educ Program. 2003;200-24
8. Rüttimann S, Clémençon D, Dubach UC. Usefulness of Complete Blood Counts as a Case-finding Tool in Medical Outpatients. Ann Intern Med. 1992;116:44-50
9. Curry IP. An Analysis of Routine Blood Testing of British Army Pilots. Aviat Space Environ Med. 2003;74:332-6
10. Boland BJ, Wollan PC, Silverstein MD. Yield of Laboratory Tests for Case-Finding in the Ambulatory General Medical Examination. Am J Med. 1996;101:142-52
11. Reichert T, DeBruyère M, Deneys V, Tötterman T, Lydyard P, Yuksel F, Chapel H, Jewell D, Van Hove L, Linden J, et al. Lymphocyte subset reference ranges in adult Caucasians. Clin Immunol Immuno-pathol. 1991;60:190-208
12. Herold G. Innere Medizin. Eine vorlesungsorientierte Darstellung. Selbstverlag, 2004
13. Thalhammer-Scherrer R, Veitl M, Exner M, Schneider B, Geissler K, Simonitsch I, Schwarzinger I. Role of immunological lymphocyte subset typing as a screening method for lymphoid malignancies in daily routine practice. Cytometry. 2000;42:5-10
14. Roche Lexikon Medizin, 3. Aufl. München: Urban & Schwarzenberg, 1993
15. Ballow M. Primary immunodeficiency disorders: Antibody deficiency. J Allergy Clin Immunol. 2002,109:581-91
16. Hammarström L, Vorechovsky I, Webster D. Selective IgA Deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol. 2000;120:225-31
17. Cunningham-Rundles C. Physiology of IgA and IgA deficiency. J Clin Immunol. 2001;5:303-9
18. Eckstein R. Immunhämatologie und Transfusionsmedizin, 5. Aufl. München und Jena: Elsevier, Urban & Fischer, 2004
19. Dube C, Rostom A, Sy R, Cranney A, Saloojee N, Garritty C et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology 2005;128: 57-67
20. Hill ID. What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations? Gastroenterology 2005;128: 25-32
21. Rostom A, Dube C, Cranney A, Saloojee N, Sy R, Garritty C et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 2005;128:38-46
22. West J, Logan RF, Smith CJ, Hubbard RB, Card TR. Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ 2004;329:716-9
23. Rajkumar SV, Gertz MA, Kyle RA, Greipp PR. Current therapy for multiple myeloma. Mayo Clin Proc 2002;77:813-22
24. Fermand JP, Ravaud P, Chevret S, Divine M, Leblond V, Belanger C et al. High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial. Blood 1998;92:3131-6
25. Segeren CM, Sonneveld P, van der Holt B, Vellenga E, Croockewit AJ, Verhoef GE et al. Dutch-Belgian Hemato-Oncology Cooperative Study Group. Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study. Blood 2003;101:2144-51